share_log

Applied Uv | 8-K/A: Current report (Amendment)

Applied Uv | 8-K/A: Current report (Amendment)

Applied Uv | 8-K/A：重大事件(修正)
美股sec公告 ·  04/05 15:24
Moomoo AI 已提取核心訊息
Applied UV, Inc., a Nevada-based company, has filed an amendment to its initial Form 8-K report with the SEC on April 5, 2024. The amendment provides additional details regarding the securities offering that closed on April 1, 2024. Specifically, it outlines a provision for the adjustment of the exercise price of the warrants issued in the private placement upon the occurrence of certain events. Applied UV issued unregistered warrants to purchase up to 518,065 shares of common stock at $16.00 per share, with the warrants being immediately exercisable for five years from the issuance date. The company is required to obtain shareholder approval within 20 days for the adjustment terms of the warrants and to disseminate an information statement to shareholders. Following shareholder approval, the exercise price of the warrants will be reduced to the lower of the current price or $0.78, and the number of shares issuable will be increased so that the total exercise price remains equivalent to the initial aggregate exercise price.
Applied UV, Inc., a Nevada-based company, has filed an amendment to its initial Form 8-K report with the SEC on April 5, 2024. The amendment provides additional details regarding the securities offering that closed on April 1, 2024. Specifically, it outlines a provision for the adjustment of the exercise price of the warrants issued in the private placement upon the occurrence of certain events. Applied UV issued unregistered warrants to purchase up to 518,065 shares of common stock at $16.00 per share, with the warrants being immediately exercisable for five years from the issuance date. The company is required to obtain shareholder approval within 20 days for the adjustment terms of the warrants and to disseminate an information statement to shareholders. Following shareholder approval, the exercise price of the warrants will be reduced to the lower of the current price or $0.78, and the number of shares issuable will be increased so that the total exercise price remains equivalent to the initial aggregate exercise price.
總部位於內華達州的Applied UV, Inc. 已於2024年4月5日向美國證券交易委員會提交了其初始8-K表報告的修正案。該修正案提供了有關2024年4月1日結束的證券發行的更多細節。具體而言，它概述了在某些事件發生時調整私募發行的認股權證的行使價的規定。Applied UV發行了未註冊的認股權證，以每股16.00美元的價格購買最多518,065股普通股，認股權證自發行之日起五年內可立即行使。公司必須在20天內獲得股東批准認股權證的調整條款，並向股東發佈信息聲明。股東批准後，認股權證的行使價將降至當前價格的較低水平，即0.78美元，並將增加可發行的股票數量，使總行使價保持等於初始總行使價。
總部位於內華達州的Applied UV, Inc. 已於2024年4月5日向美國證券交易委員會提交了其初始8-K表報告的修正案。該修正案提供了有關2024年4月1日結束的證券發行的更多細節。具體而言，它概述了在某些事件發生時調整私募發行的認股權證的行使價的規定。Applied UV發行了未註冊的認股權證，以每股16.00美元的價格購買最多518,065股普通股，認股權證自發行之日起五年內可立即行使。公司必須在20天內獲得股東批准認股權證的調整條款，並向股東發佈信息聲明。股東批准後，認股權證的行使價將降至當前價格的較低水平，即0.78美元，並將增加可發行的股票數量，使總行使價保持等於初始總行使價。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息